the aid library

LIST OPTIONS

Filter

1227

Sort by:

Direction:

Download (97)

View PDF (126)

AIDS Free Framework to accelerate paediatric and adolescent HIV treatment

World Health Organization; Elizabeth Glaser Foundation; Unicef; et al. (2018) C_WHO

Download (171)

View PDF (163)

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

E. J. Abrams; J. Ananworanich; M. Archary; M.N. Ngongondo; P. Brouwers J Acquir Immune Defic Syndr; Pub Med (2018) C2

J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

Download (103)

View PDF (145)

Toolkit for research and development of paediatric antiretroviral drugs and formulations

World Health Organization (WHO); Unitaid; Unicef; et al. World Health Organization (WHO); Unitaid; Unicef; et al. (2018) C_WHO

WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group

Download (255)

View PDF (471)

Botswana Country Operational Plan 2017 Strategic Direction Summary

PEPFAR (2017) C1

Download (284)

View PDF (434)

South African Antimicrobial Resistance National Strategy Framework. A One Health Approach 2018 – 2024

Dept. of Health ; Dept of Agriculture, Forestry & Fisheries, South Africa (2018) C1

Download (229)

View PDF (265)

Pharmaceutical Services in Mozambique: foreign aid in public provision of medicines

Sachy, M; Almeida C; Pepe VLE (2018) CC

This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ... more

Download (225)

View PDF (367)

mhGAP operations manual

World Health Organization WHO (2018)

mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG) for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool for assessing and managing p... more

Download (240)

View PDF (412)

Analysis of drug markets - Opiates, cocaine, cannabis, synthetic drugs

United Nations Office on Drugs and Crime (2018) C2

World Drug Report 2018 -3-

Download (569)

View PDF (1130)

WHO Competency Framework for Health Workers’ Education and Training on Antimicrobial Resistance

World Health Organization WHO (2018) C_WHO

The framework is to be used as a reference guide, applied according to local priorities and needs, and targeted at academic institutions, educators, accreditation bodies, regulatory agencies and other users. The ultimate aim is to ensure that all health workers are equipped with the requisite compet... more

Download (398)

View PDF (696)

Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure

World Health Organization WHO (2018) C_WHO

This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from... more

Download (133)

View PDF (166)

Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A WHO practical toolkit

World Health Organization WHO (2019) C_WHO

Stewardship is defined as “the careful and responsible management of something entrusted to one’s care”. It was originally applied in the health-care setting as a tool for optimizing antimicrobial use, termed “antimicrobial stewardship” (AMS). Stewardship has since be... more

Download (164)

View PDF (164)

The Core Elements of Hospital Antibiotic Stewardship Programs: 2019

Centers for Disease Control and Prevention CDC (2019) C_CDC

This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti... more

Download (125)

View PDF (137)

National Action Plan for Combating Antimicrobial Resistance In the Hashemite Kingdom of Jordan (2018-2022)

Ministry of Health Jordan (2018) C_WHO

The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.

Download (124)

View PDF (163)

Sierra Leone: National Strategy Plan for Combating Antimicrobial Resistance

Ministry of Health and Sanitation Sierra Leone (2018) C_WHO

Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ... more

Download (130)

View PDF (150)

WHO recommendations Uterotonics for the prevention of postpartum haemorrhage Web Annex 5

World Health Organization (2018) C_WHO

Web annex 5: Oxytocin and ergometrine versus placebo or no treatment Evidence to decision framework

Download (105)

View PDF (147)

Nutritional interventions update: vitamin D supplements during pregnancy

World Health Organization WHO (2020) C_WHO

The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during p... more

Download (190)

View PDF (117)

National Drug Information Service Training Course for Pharmacists. Participant's Manual

Ministry of Health, Federal Democratic Republic of Ethiopia (2018) CC

The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein... more

Download (450)

View PDF (233)

Extemporaneous Dosage Forms: Oral Liquids

Nguyen, T. The Australian College of Pharmacy (2019) CC

After completing this activity, pharmacists should be able to: 1. List populations for which the compounding of an oral liquid may be necessary 2. Outline necessary considerations that should be made by the pharmacist to ensure product stability 3. Describe methods used in the compounding of liqu... more

Download (214)

View PDF (209)

Antimicrobial Resistance Background Document

National Department of Health South Africa (2019) C1

Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ... more

Download (137)

View PDF (173)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more